The company is pulling eight product types, including 175,000 units of tubing, 32,000 IV administration sets and 24,400 fluid transfer sets. The reason for the recall is because of a potential leaking issue, which can lead to a delay in therapy, increased risk of bloodstream infection and exposure risk of hazardous drugs.
“There is also the potential for life-threatening situations to occur requiring additional medical intervention,” the FDA post said. The database does not report adverse events.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.